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Abstract 
 
Recombination between HIV-1 subtypes B and F has generated several 
circulating and unique recombinant forms, particularly in Latin American areas. 
In Italy, subtype B is highly prevalent while subtype F is the most common pure 
non-B subtype. To investigate the recombination pattern in Italian BF 
recombinant viruses, we characterized full-length sequences derived from 15 
adult patients, mostly Italian and infected by heterosexual route. One of the BF 
mosaics was a CRF29, three sequences clustered with low bootstrap values with 
CRF39, CRF40 and CRF42. With the exception of the CRF29-like sequence, the 
other recombination patterns were unique but two possible clusters were 
identified. Analysis of the gp120 V3 domain suggested a possible link with 
subtype F from Eastern Europe rather than from Latin America, favoring the 
hypothesis of local recombination between clade B and F viruses over that of 
import of BF recombinants from Latin America. HIV-1 subtypes B and F appear 
prone to generation of unique recombinants in Italy, warranting epidemiological 
surveillance and investigation of a possible clinical significance. 
 
 
 
 
 
 
 
 
Human Immunodeficiency Virus type 1 (HIV-1) is characterized by an extremely 
broad genetic diversity, caused by high mutation and recombination rates. 
Currently, HIV-1 group M (“Major”), which is responsible of the worldwide 
pandemic, is divided into pure subtypes A-D, F-H, J, K (with subtypes A and F 
further subdivided into sub-subtypes A1-A4 and F1-F2, respectively) as well as 
48 Circulating Recombinant Forms (CRFs) of varying epidemiological significance, 
and untold numbers of unique recombinants which are not known to have spread 
to many patients. Subtype B has been long predominant in Western European 
countries but the prevalence of non-B strains has been increasing significantly in 
latest years as a consequence of recent migration waves from Africa, Eastern 
Europe and South America1. Continuous surveillance of HIV-1 molecular 
epidemiology plays a critical role in the understanding of genetic diversity of HIV-
1 and for research purposes such as vaccine development. In clinical practice, 
pol-based subtype assignment is usually accomplished as a by-product of 
genotypic antiretroviral resistance testing.  
A homebrew HIV-1 genotyping assay has been established and offered as a 
public health service at the HIV Monitoring Laboratory (HML), Department of 
Molecular Biology, University of Siena, Italy since 19952. The laboratory has been 
serving a number of clinics for analysis of drug resistance mutations 
accumulating around 10,000 protease and reverse transcriptase sequences from 
more than 4,000 patients. In addition, some hundred partial gag and env 
sequences have been obtained for research studies. A recent survey on the 
whole HIV-1 sequence database at the HML revealed 85% of subtype B 
sequences and 15% of non-B subtypes, mainly CRF02_AG, F1, C and A1, based 
on the pol region3. In some cases, assignment of subtype based on pol and env 
regions were not in agreement4. These discrepancies mostly involved subtypes B 
and F1. In addition, other sequences showed BF1 mosaics within the individual 
pol or env region. Since BF recombinants have been previously reported in Latin 
America5-11, we were interested in analyzing BF mosaic forms circulating in Italy.  
Samples from 15 adult patients (12 males, three females) collected in four 
hospitals of Tuscany and Umbria regions were selected for near full-length 
sequencing based on peripheral blood mononuclear cell (PBMC) DNA availability 
and identification of a BF pol sequence or discordant BF pol and env. Twelve 
patients were Italian, two were Brazilian patients living in Italy and 1 was a 
Tunisian patient; most of the patients acquired HIV-1 infection via sexual 
intercourses, only one patient contracted HIV-1 infection through drug injection 
(Table 1). To obtain full-length sequence information, PBMC DNA was subjected 
to a 9.010-base pair pre-amplification step12 followed by multiple nested PCRs 
generating overlapping sub-genomic fragments. The LTR region, not comprised 
in the large outer amplicon, was obtained separately using outer primers MZ28 
(coordinates 60-79 in HIV-1 HXB2) and LR56 (1488-1507) and inner primers 
P221 (87-100) and P82 (1478-1505). PCR products were sequenced on both 
strands using multiple infrared-labeled primers and sequencing products were 
resolved with a Licor IR2 dual-laser automated sequencer. PCR and sequencing 
primer sequences are available on request. Nucleotide sequences were edited 
and assembled by the DNAstar SeqMan II module. For phylogenetic analysis, 
full-length sequences were compared with full-length subtype reference 
sequence alignments obtained from the Los Alamos National Laboratory HIV 
Sequence Database (http://www.hiv.lanl.gov/). The alignment contained 
nucleotide sequences of all HIV-1 group M subtypes and known CRFs with BF 
mosaics. The HIV-1 group O sequence SEMP1300 was introduced in the 
alignment as the outgroup for the phylogenetic tree. The sequence dataset was 
manually managed using the BioEdit program, version 5.0.9 
(http://www.mbio.ncsu.edu/BioEdit/bioedit.html/) (T. Hall, North Carolina State 
University, Raleigh, NC). Phylogenetic analysis was performed with PAUP4b10 
software. Neighbor joining and maximum likelihood trees were constructed based 
on the fittest nucleotide substitution models determined by Modeltest v3.7. The 
reliability of the tree topology was assessed by bootstrapping with 1,000 
replicates. The recombination patterns were determined by bootscanning 
analysis with Simplot v3.5.1 
(http://sray.med.som.jhmi.edu/SCRoftware/simplot/), using a window of 400 nt, 
moving in 50 nt increments, which made it possible to assign segments to 
subtypes B and F1 with a bootstrap support ≥70%. Prediction of coreceptor use 
was done by using the geno2pheno[coreceptor] algorithm at the 10% false 
positive rate (http://coreceptor.bioinf.mpi-inf.mpg.de/).  
Phylogenetic analysis of the near full-length sequences is shown in Fig. 1. 
Sample 59211 was identified as a CRF29, while samples 83166, 30638 and 
85037 clustered with low bootstrap values with CRF39, CRF40 and CRF42, 
respectively. Bootscanning analysis showed the high genetic diversity between 
reference sequences and our BF mosaics, which are mostly characterized by 
unique recombination patterns. Two distinct clusters of BF sequences shared a 
similar recombination pattern, as shown in Fig. 2. Each BF cluster may have 
originated from a common ancestor circulating among people living in the same 
geographical area. Further recombination events may then have introduced 
different breakpoints contributing to diversification within the same cluster. This 
hypothesis is supported by greater sequence similarity among members of 
cluster 1 and among members of cluster 2, than between clusters or the unique 
recombinants. Cluster 2 showed a high degree of relatedness and may represent 
a new circulating recombinant form if complete genomes of other isolates are 
completed in the future. 
BF recombinants where first isolated and characterized in Argentina, where they 
have been circulating since mid-80’s5, and later in Brazil6. The presence of these 
recombinants and related unique mosaic strains increased over the years, 
favored by the high number of injecting drug users, sexual contacts and the 
cocirculation of subtype B, F and BF viruses in the same populations7,8. 
Afterwards, BF mosaics were described in other Southern America countries9,10 
as well as in European countries like Spain13 and Luxembourg (where CRF42_BF 
has been isolated). Recently, a full-length sequence of a BF recombinant strain 
with a unique mosaic pattern has been characterized in Italy14 in a patient with 
multiple risk factors and found to be phylogenetically related to two other 
sequences from Brazil. Most of the BF genomes described in this study were 
acquired via heterosexual contacts. BF mosaics could have been imported into 
Italy from Southern America or locally generated by independent recombination 
events between subtype B, which is predominant in Italy, and subtype F1, which 
is the most frequent non-B pure subtype circulating in Italy. The migration flow 
from South America to Italy and sexual tourism in Brazil could support the first 
hypothesis. Although most of the sequences reported here do not seem to be 
related to the CRFs originated in Brazil or Argentina and other BF sequences 
found in GenBank (data not shown), phylogenetic analysis of the pol region 
indicated that of the seven BF recombinants with an F1 pol are more similar to 
the F1 subtype circulating in South America than to that circulating in Eastern 
Europe (supplementary Figure 1).  
Analysis of the gp120 V3 loop sequence predicted 11 CCR5-tropic and 4 CXCR4-
tropic viruses. The V3 crown tetrapeptide was GPGR in 11/15 (73.3%) 
sequences, GPGQ in 2/15 (13.3%), GPGG and GPGK in the other two cases. 
Among 9 clade B V3 sequences, GPGR motif was observed in 7 cases, while the 
other 2 sequences had GPGG and GPGK motifs. Among 6 clade F1 V3 sequences, 
GPGR was found in 4 cases and GPGQ in the other 2 samples. None of the 
samples with subtype B V3 region had the GWGR motif, which is common in 
clade B viruses circulating in Brazil but not in other countries15,16. Interestingly, 
two of the subtype F1 V3 sequences had the GPGQ crown variant, which is 
largely prevalent in Romania and is not present in Brazilian F1 (mostly GPGR). 
Thus, this last finding could support the hypothesis of the local origin of BF 
recombinants due to the co-circulation of the subtype B and F1.  
 
The appearance of these mosaic structures in Italy can be compared to that 
occurred in Argentina, where subtype B was predominant before the introduction 
of subtype F1. Actually, the prevalence of BF recombinants has been increasing 
in Latin American countries, becoming the most common genetic form and 
causing the disappearance of pure subtype F in some areas5,15. The high 
propensity for subtype B and F to recombine could be explained by a higher 
fitness compared with pure subtype B and F111. To test this hypothesis, 
extensive in vitro analysis of chimeric viruses is required to investigate the 
interaction among subgenomic regions from each subtype17. In general, the 
prevalence of BF, as well as other, mosaic structures is probably underestimated 
due to large scale partial genotyping of clinical samples for antiretroviral 
resistance testing. Along with upcoming availability of effective technologies for 
large scale sequencing, information on full-length HIV genomes is expected to 
expand providing an accurate picture of virus diversification in different areas 
over time.  
 
Sequence data 
GenBank accession numbers of the sequences are GU595148 - GU595162. 
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Table 1. Epidemiological data of the patients included in this study. 
 
Patient 
sample 
Year of HIV 
diagnosis 
Year of sample 
collection  
Sex Nationality Mode of transmission 
30638 1990 1999 M Italian Bisexual 
61842 1994 2002 F Italian Heterosexual 
79867 1994 2005 M Brazilian ? 
57954 1995 2002 M Italian Heterosexual 
59211 1998 2002 M Italian Heterosexual 
89072 1998 2006 M Brazilian ? 
85037 1999 2005 M Italian Homosexual 
50610** 2001 2001 F Italian ? 
50612** 2001 2001 M Italian ? 
53143* 2001 2001 M Italian Heterosexual 
58736* 2002 2002 M Italian Heterosexual 
59352** 2002 2002 F Italian Heterosexual 
62136* 2002 2002 M Italian Heterosexual 
83166 2005 2005 M Italian ? 
104045 2007 2007 M Tunisian Intravenous drug user 
 
*Cluster 1 sequences and **Cluster 2 sequences based on phylogenetic tree as shown in figure 1. 
 
 
 
 
  
